Analysis of neonatal phenylketonuria and congenital hypothyroidism screening in Sichuan province from 2000 to 2009
- OU Ming-cai,ZHANG Yu,HU Qi,ZHOU Jing-yao,WANG Rui
Author information
+
History
+
Abstract
Objetive To analyze the results of neonatal phenylketonuria(PKU) and congenital hypothyroidism(CH) screening of Sichuan province from 2000 to 2009 and provide scientific basis for health bureau to make decision. Methods The medical staff of blood collection units carried out health education of neonatal screening,collected,saved and delivered the newborn blood samples after parents informed consent;The medical staff of the neonatal screening center accepted the blood samples timely,detected the qualified samples for screening of PKU and CH,reviewed the suspicious or positive results,noticed the confirmed positive results. Results The neonatal screening rate and coverage rate were increased significantly year by year in Sichuan province from 2000 to 2009,the neonatal screening rate reached 67.50%,the coverage rate of city (state) reached 100%,the coverage rate of county (district) reached 87.29%,the coverage rate of blood collection units reached 90.98% in 2009;In total there were 1 721 340 newborns screened from 2000 to 2009,67 cases of PKU were identified with a detectable rate of 1∶25 692,699 cases of CH were identified with a detectable rate of 1∶2 573. Conclusions The work of neonatal PKU and CH screening in Sichuan province has achieved significant results in the past 10 years,it has showed obvious social benefits.The current rate of neonatal screening have room to improve further,screening work remained to be in-depth further.
Key words
neonatal disease screening / congenital hypothyroidism / phenylketonuria
{{custom_sec.title}}
{{custom_sec.title}}
References
[1] 顾学范,叶军.新生儿疾病筛查[M].上海:上海科学技术文献出版社,2003:260-265.
[2] Sahai I,Marsden D.Newborn screening[J].Critical Reviews in Clinical Laboratory Science,2009,46:55-82.
[3] Fingerhut R,Olgemller B.Newborn screening for inborn errors of metabolism and endocrinopathies:an update[J].Anal Bioanal Chem,2009,393:1481-1497.
[4] Tarini BA.The current revolution in newborn screening:new technology,old controversies[J].Arch Pediatr Adolesc Med,2007,161:767-772.
[5] 顾学范,王治国.中国580万新生儿苯丙酮尿症和先天性甲状腺功能减低症的筛查[J].中华预防医学杂志,2004,38(1):99-102.
[6] 黄晓春,伍小秋,黄荣彬,等.深圳市1998-2008年新生儿疾病筛查结果分析[J].中国新生儿科杂志,2009,24(2):220-222.
[7] 满晓玮,张知新,顾学范,等.新生儿疾病筛查工作的成本一效益分析[J].中国卫生经济,2011,30(5):91-93.
[8] 樊欣,周晓军,昌惠敏,等.重庆市新生儿疾病筛查12年结果回顾性分析[J].重庆医学,2009,38(24):3058-3059.
[9] 孔元原,张玉敏,裘蕾,等.北京市20年新生儿疾病筛查回顾性分析[J].中国新生儿科杂志,2011,26(2):87-90.
[2] Sahai I,Marsden D.Newborn screening[J].Critical Reviews in Clinical Laboratory Science,2009,46:55-82.
[3] Fingerhut R,Olgemller B.Newborn screening for inborn errors of metabolism and endocrinopathies:an update[J].Anal Bioanal Chem,2009,393:1481-1497.
[4] Tarini BA.The current revolution in newborn screening:new technology,old controversies[J].Arch Pediatr Adolesc Med,2007,161:767-772.
[5] 顾学范,王治国.中国580万新生儿苯丙酮尿症和先天性甲状腺功能减低症的筛查[J].中华预防医学杂志,2004,38(1):99-102.
[6] 黄晓春,伍小秋,黄荣彬,等.深圳市1998-2008年新生儿疾病筛查结果分析[J].中国新生儿科杂志,2009,24(2):220-222.
[7] 满晓玮,张知新,顾学范,等.新生儿疾病筛查工作的成本一效益分析[J].中国卫生经济,2011,30(5):91-93.
[8] 樊欣,周晓军,昌惠敏,等.重庆市新生儿疾病筛查12年结果回顾性分析[J].重庆医学,2009,38(24):3058-3059.
[9] 孔元原,张玉敏,裘蕾,等.北京市20年新生儿疾病筛查回顾性分析[J].中国新生儿科杂志,2011,26(2):87-90.





